Sanofi India Ltd

₹3,103.15▼ -1.17%28 Sept

📊 Stock Analysis

Market Data

Market Cap₹7,146.75 Cr.

52W High₹4,896

Current Price₹3,103.15

52W Low₹3,050

Down from 52W High36.6 %

Face Value₹10

Performance

ROCE50.3 %

ROE48.02 %

EPS (TTM)₹39.64

EPS Prev Qtr₹35.69

EPS Last Year₹59.31

EBITDA Qtr₹108.7 Cr.

Book Value₹374

Financial Health

Debt/Equity0

Debt/Profit0

Total Assets₹1,611.8 Cr.

Dividend Yield3.77 %

Promoter Holding60.4 %

Earning Power28.17 %

Valuation

Stock P/E17.29

Industry P/E33.81

Price to Book8.3

Price to Sales3.55

Graham Number₹1,228.64

Key Metrics

Face Value

₹10

About Sanofi India Ltd

Healthcare · Pharmaceuticals

Sanofi India Ltd is listed on NSE in the Healthcare / Pharmaceuticals sector. Face value ₹10. Market cap ₹7,146.75 Cr.

Price Chart

Peer Comparison

Name	CMP	P/E	Market Cap	Div Yield	NP Qtr	Qtr Profit Var%	Sales Qtr	Qtr Sales Var%	ROCE%	Debt/Eq
Sun Pharmaceutical Industries Ltd	-	36.51	₹4,41,477.63 Cr	0.87%	₹12,172.7 Cr	-	₹59,910.52 Cr	-	18.72%	0.05
Divis Laboratories Ltd	-	86.48	₹2,53,031.38 Cr	0.31%	₹2,925 Cr	-	₹11,230 Cr	-	23.04%	0
Torrent Pharmaceuticals Ltd	-	77.67	₹1,85,216.32 Cr	0.78%	₹2,156 Cr	-	₹15,723 Cr	-	15.1%	1.76
Zydus Lifesciences Ltd	-	27.01	₹1,20,897.46 Cr	0.08%	₹4,492.2 Cr	-	₹28,591.7 Cr	-	16.76%	0.43
Cipla Ltd	-	33.28	₹1,12,201.64 Cr	0.94%	₹3,364.84 Cr	-	₹28,324.4 Cr	-	13.24%	0.01
Laurus Labs Ltd	-	99.31	₹1,08,698.22 Cr	0.06%	₹1,090.76 Cr	-	₹7,269.64 Cr	-	20.79%	0.45
Dr Reddys Laboratories Ltd	-	31.6	₹1,02,039.12 Cr	0.65%	₹3,183.3 Cr	-	₹33,227.9 Cr	-	10.05%	0.17
Mankind Pharma Ltd	-	49.29	₹1,00,752.43 Cr	0.04%	₹2,067.57 Cr	-	₹14,737.88 Cr	-	13.95%	0.38
Aurobindo Pharma Ltd	-	26.56	₹97,814.24 Cr	0.24%	₹3,710.8 Cr	-	₹34,935.29 Cr	-	12.75%	0.2
Lupin Ltd	-	16.64	₹94,274.49 Cr	0.87%	₹5,550.99 Cr	-	₹29,966.58 Cr	-	27.95%	0.26
Glenmark Pharmaceuticals Ltd	-	36.67	₹65,922.11 Cr	0.11%	₹1,797.81 Cr	-	₹17,736.56 Cr	-	24.78%	0.25
Alkem Laboratories Ltd	-	28.65	₹61,804.34 Cr	1.03%	₹2,206.3 Cr	-	₹15,081.28 Cr	-	19.75%	0.12
Biocon Ltd	-	110.29	₹61,113.53 Cr	0.13%	₹416.4 Cr	-	₹17,321.1 Cr	-	2.87%	0.43
Abbott India Ltd	-	35.22	₹56,860.69 Cr	1.78%	₹1,614.68 Cr	-	₹7,004.38 Cr	-	45.73%	0
Glaxosmithkline Pharmaceuticals Ltd	-	46.73	₹49,091.33 Cr	1.97%	₹1,068.15 Cr	-	₹3,954.94 Cr	-	64.07%	0
Ipca Laboratories Ltd	-	36.13	₹48,712.48 Cr	0.31%	₹1,379.76 Cr	-	₹10,125.58 Cr	-	21.48%	0.09
Anthem Biosciences Ltd	-	83.03	₹47,949.68 Cr	0.23%	₹575.95 Cr	-	₹2,002.34 Cr	-	25.5%	0.02
Gland Pharma Ltd	-	42.26	₹47,764.08 Cr	0.69%	₹1,128.8 Cr	-	₹6,725.3 Cr	-	15.21%	0.02
Ajanta Pharma Ltd	-	38.87	₹44,109.77 Cr	0.79%	₹1,134.88 Cr	-	₹5,776.17 Cr	-	31.81%	0.05
J B Chemicals & Pharmaceuticals Ltd	-	53.3	₹38,730.77 Cr	0.39%	₹709.46 Cr	-	₹4,147.79 Cr	-	23.03%	0

Quarterly Results

	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	510.8	463.5	524	514.9
↳ QoQ Growth	-	-9.3%	+13.1%	-1.7%
Expenses	382.8	356.8	413.3	406.2
Operating Profit	128	106.7	110.7	108.7
OPM %	25.06%	23.02%	21.13%	21.11%
Other Income	3.5	4.8	2.3	5.9
Interest	0.3	0.4	0.4	0.4
Depreciation	9.1	9	9	9.6
EBITDA	137.1	115.7	119.7	118.3
EBITDA Margin %	26.84%	24.96%	22.84%	22.98%
Profit Before Tax	104.5	92.1	112.6	122.2
Tax %	31.1%	25.95%	27%	25.29%
Net Profit	136.6	103.2	82.2	91.3
↳ QoQ Growth	-	-24.5%	-20.3%	+11.1%
EPS	59.31	44.81	35.69	39.64

Balance Sheet

	Mar 2024	Mar 2025
Equity Capital	23	23
Reserves	992.2	837.6
Borrowings	19	0
Other Liabilities	680.6	751.2
Total Liabilities	1714.8	1611.8
Fixed Assets	310	312.5
CWIP	13.3	18.1
Investments	0	0
Other Assets	1391.5	1281.2
Total Assets	1714.8	1611.8

Cash Flows

	Mar 2025
Cash from Operating Activity	461.5
Cash from Investing Activity	-19.2
Cash from Financing Activity	-392.4
Net Cash Flow	49.9

Shareholding Pattern

	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters %	60.4%	60.4%	60.4%	60.4%
FIIs %	5.57%	5.55%	5.64%	5.69%
DIIs %	22.29%	21.31%	21.13%	19.87%
Public %	9.08%	10.02%	10.19%	11.38%
No. of Shareholders	71,395	75,813	75,758	80,005